https://www.bioworld.com/articles/690901-immunic-slammed-as-drug-placebo-similar-in-phase-i-psoriasis-trial
Immunic slammed as drug, placebo similar in phase I psoriasis trial | BioWorld
A preview of the next edition of BioWorld, Oct. 21, 2022
https://magnifi.com/stocks/IMUX
Immunic, Inc. (IMUX) | Magnifi
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory...
immunicincimuxmagnifi
https://www.clinicaltrialsarena.com/news/immunic-data-rrms-trial/
Immunic unveils data from RRMS therapy trial
Oct 12, 2023 - Immunic has unveiled data from the Phase II trial evaluating vidofludimus calcium in patients with relapsing-remitting multiple sclerosis.
immunicunveilsdatatherapytrial
https://imux.com/immunic-inc-to-participate-in-scientific-and-investor-conferences-in-september-2/
Immunic, Inc. to Participate in Scientific and Investor Conferences in September 2020
Immunic, Inc. (Nasdaq: IMUX), today announced participation in the following scientific and investor conferences in September 2020
to participateinvestor conferencesimmunicinc